Catalytic antibodies, also known as abzymes, are antibodies engineered to have catalytic activity. These can be designed to recognize and bind to specific cancer-related antigens, catalyzing reactions that neutralize or destroy cancer cells. This approach combines the specificity of antibodies with the catalytic efficiency of enzymes.
